Skip to main content
Clinical Trials/NCT05629481
NCT05629481
Recruiting
Not Applicable

a Prospective Single-center, Participant-blinded, Randomized Controlled Clinical Trial of Fractional Carbon Dioxide Laser Treatment for Female Stress Urinary Incontinence

Qilu Hospital of Shandong University1 site in 1 country120 target enrollmentApril 20, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stress Urinary Incontinence
Sponsor
Qilu Hospital of Shandong University
Enrollment
120
Locations
1
Primary Endpoint
treatment efficacy
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Urinary incontinence (UI) is a common disease that refers to involuntary loss of urine. The prevalence of female UI varies widely across different studies, mostly ranging from 25-40%. Stress urinary incontinence (SUI) is the most common type of UI. SUI is defined as involuntary loss of urine when abdominal pressure increases suddenly such as coughing or sneezing. SUI affects women's quality of life seriously, causing psychological problems such as anxiety and depression, even socialization difficulties. There are many treatment options for female SUI, including non-surgical and surgical interventions. Clinicians and patients need a highly effective and low-risk therapy urgently, thus energy-based therapies were born on demand. This study aims to demonstrate the efficacy and safety of the fractional CO2 laser in the treatment of female SUI, as well as its impact on women's quality of life.

Detailed Description

Urinary incontinence (UI) is a common disease that refers to involuntary loss of urine. The prevalence of female UI varies widely across different studies, mostly ranging from 25-40%. Stress urinary incontinence (SUI) is the most common type of UI. SUI is defined as involuntary loss of urine when abdominal pressure increases suddenly such as coughing or sneezing. SUI affects women's quality of life seriously, causing psychological problems such as anxiety and depression, even socialization difficulties. There are many treatment options for female SUI, including non-surgical and surgical interventions. For example, pelvic floor muscle training (PFMT) is the primary non-surgical treatment method, requiring females to perform Kegel exercises consistently. PMFT has been shown to be effective for female SUI, but the efficacy is dependent on the quality of PMFT. Outpatient PFMT has a higher objective cure rate compared with home PFMT. Surgery is the most effective treatment option, and the most common procedure is the mid-urethral sling (MUS). Nevertheless, surgical risks such as persistent pain after surgery, bleeding, infection, and urinary dysfunction cannot be ignored. Many outpatients are unable to persist in performing high-quality PFMT and do not consent to surgical treatment. Clinicians and patients need a highly effective and low-risk therapy urgently, thus energy-based therapies were born on demand.The result of energy-based therapies including radiofrequency (RF), Erbium: YAG (Er: YAG) laser, and CO2 laser is controversial, which has been reported in several papers. This study aims to demonstrate the efficacy and safety of the fractional CO2 laser in the treatment of female SUI, as well as its impact on women's quality of life.

Registry
clinicaltrials.gov
Start Date
April 20, 2022
End Date
April 20, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yueqing Tang

Principal Investigator

Qilu Hospital of Shandong University

Eligibility Criteria

Inclusion Criteria

  • Women aged 18-70 years
  • Clinical diagnosis of stress urinary incontinence (SUI)

Exclusion Criteria

  • pregnancy
  • pelvic organs prolapse no more than grade II
  • gynecologic and urinary tract infections
  • previous surgical intervention for stress urinary incontinence (SUI)
  • Urgency urinary incontinence (UUI) or Mixed urinary incontinence (MUI)
  • serious chronic disease or other reasons that compromised safety and interfered with study compliance

Outcomes

Primary Outcomes

treatment efficacy

Time Frame: through study completion, an average of 6 months

1-hour pad test, used to assess improvement in the amount of urine leakage. That pad weight increases \>2g is considered positive. The improvement criteria was considered as 1-h pad test weight decreasing \> 50% baseline.

Secondary Outcomes

  • King's Health Questionnaire (KHQ) score decreases more than 50% baseline(through study completion, an average of 6 months)
  • Incontinence-specific Quality of Life (I-QOL) score increases more than 50% baseline(through study completion, an average of 6 months)

Study Sites (1)

Loading locations...

Similar Trials